Factors related to post‐treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy

Abstract

To prevent relapse in patients with chronic hepatitis B infection after lamivudine therapy, age and serum bilirubin level of patients as well as a prolonged duration of additional lamivudine therapy should be considered.